Copyright
©The Author(s) 2022.
World J Gastroenterol. Aug 7, 2022; 28(29): 3767-3779
Published online Aug 7, 2022. doi: 10.3748/wjg.v28.i29.3767
Published online Aug 7, 2022. doi: 10.3748/wjg.v28.i29.3767
B and C Findings in systemic mastocytosis |
B Findings |
BM biopsy showing > 30% infiltration by MCs (focal, dense aggregates) and serum total tryptase level > 200 ng/mL |
Myeloproliferation or signs of dysplasia in non-MC lineage(s), no prominent cytopenias; criteria for AHN not met |
Hepatomegaly and/or splenomegaly on palpation without impairment of organ function and/or lymphadenopathy on palpation/imaging (> 2 cm) |
C Findings1 |
Cytopenia(s): ANC < 1 × 109/L, Hb < 10 g/dL, or platelets < 100 × 109/L |
Hepatomegaly on palpation with impairment of liver function, ascites, and/or portal hypertension |
Skeletal lesions: Osteolyses and/or pathologic fractures |
Palpable splenomegaly with hypersplenism |
Malabsorption with weight loss from gastrointestinal tract MC infiltrates |
- Citation: Elvevi A, Elli EM, Lucà M, Scaravaglio M, Pagni F, Ceola S, Ratti L, Invernizzi P, Massironi S. Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review. World J Gastroenterol 2022; 28(29): 3767-3779
- URL: https://www.wjgnet.com/1007-9327/full/v28/i29/3767.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i29.3767